ATLANTA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding Nutex’s business, operations, and prospects, including allegations that: (i) HaloMD was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance com ...

Core Viewpoint - A shareholder class action lawsuit has been filed against Altimmune, Inc. alleging that the company made materially false and misleading statements regarding the results of the IMPACT Phase 2b MASH trial, particularly concerning inflated expectations and undisclosed adverse information related to the placebo group's responses [1] Group 1: Lawsuit Details - The lawsuit claims that Altimmune consistently promoted inflated expectations for positive topline results from the IMPACT Phase 2b MASH trial [1] - It is alleged that the company concealed higher responses in the placebo group, which could negatively impact the topline results [1] Group 2: Shareholder Information - Shareholders who purchased Altimmune shares between August 10, 2023, and June 25, 2025, and experienced significant losses are encouraged to discuss their legal rights [2] - The deadline for shareholders to request to be appointed as lead plaintiff in the case is October 6, 2025 [3] Group 3: Legal Representation - Holzer & Holzer, LLC is a law firm specializing in securities litigation and has a history of recovering significant amounts for shareholders affected by corporate misconduct [3] - The firm has been recognized as an ISS top-rated securities litigation law firm for 2021, 2022, and 2023 [3]

Core Points - A shareholder class action lawsuit has been filed against Flywire Corporation, alleging that the company made materially false and misleading statements regarding its revenue growth and the impact of permit and visa-related restrictions on its business [1] - The lawsuit claims that the strength and sustainability of Flywire's revenue growth was overstated, and the negative impacts of regulatory restrictions were understated [1] - The lawsuit indicates that these misleading statements were made at all relevant times, affecting the company's public perception and potentially its stock performance [1] Legal Information - Shareholders who purchased Flywire shares between February 28, 2024, and February 25, 2025, and experienced significant losses are encouraged to discuss their legal rights [2] - The deadline for shareholders to request to be appointed as lead plaintiff in the case is September 23, 2025 [3] - Holzer & Holzer, LLC is representing the shareholders in this litigation and has a history of recovering significant amounts for investors affected by corporate misconduct [3]

Core Points - A shareholder class action lawsuit has been filed against Open Lending Corporation, alleging that the company made materially false and misleading statements regarding its business and operations [1] - The lawsuit claims that Open Lending misrepresented the capabilities of its risk-based pricing models and issued misleading statements about its profit share revenue [1] - It is alleged that Open Lending failed to disclose that its 2021 and 2022 vintage loans were worth significantly less than their outstanding loan balances [1] - The lawsuit also claims that the company misrepresented the underperformance of its 2023 and 2024 vintage loans [1] Legal Context - Shareholders who purchased Open Lending shares between February 24, 2022, and March 31, 2025, and suffered significant losses are encouraged to discuss their legal rights [2] - The deadline to request to be appointed lead plaintiff in the case is June 30, 2025 [3] - Holzer & Holzer, LLC is representing shareholders in this litigation and has a history of recovering significant amounts for shareholders affected by corporate misconduct [3]